Actively Recruiting
Study of Dietary Strategies Using Fructose and Galactose Intake in Adults with Glycogen Storage Disease Type I to Improve Metabolic Control and Quality of Life
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2026-05-12
20
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the metabolic effects of dietary changes involving controlled intake of fructose and fructosegalactose in adults with Glycogen Storage Disease Type I GSDI. This study aims to determine whether relaxing dietary restrictions on these sugars is safe and could improve food choices and quality of life for patients with this rare disorder. The research assesses traditional metabolic control markers and uses advanced metabolomics and lipidomics for a broad analysis. The study involves two dietary intervention groups one with added fructose intake 40g, including up to 25g from added sugars and another with added fructose plus galactose 10g galactose mostly from lactose plus 40g fructose. These interventions are compared against the participants usual diet over a 4-week period to observe changes in metabolic markers. Participants will undergo assessments of blood lactate, triglycerides, uric acid, and plasma metabolites before and after the dietary interventions. Researchers will monitor these parameters to evaluate metabolic control and safety. The main outcome is the change in blood lactate levels during the intervention compared to baseline. The study lasts at least 4 weeks, with regular monitoring to understand the impact of dietary changes on metabolic health in adult GSDI patients.
CONDITIONS
Brief Title
Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I
Research Team
M
Michel Hochuli, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here